The neonatal cell supplier of choice
We are the source behind the cure ›
Alvion Bio is the upstream supplier of neonatal MSCs. We make and supply 
, so the developers, clinicians and researchers we partner with can make the cures.
What sets us apart
Alvion Bio is a supply company, not a therapeutics company. We do not develop or sell therapies, and we do not treat patients. We make and supply technology, so our partners can make new therapies.
The meaning behind the names
The source of life, and renewal made real ›
Our story begins where every life begins: the amniotic fluid that surrounds and protects a developing child. Alvion evokes the amnion, the protective membrane that cradles new life, together with the idea of vitality. It frames us as the careful keeper of that first vessel of life.
suggests renewal, paired with “-xis”, a turning point reached: the moment a body begins to mend. Alvion makes the cells. is the cells. Our partners make the cures.
A Swedish invention. The technology behind originated with clinicians at Skåne University Hospital Malmö, and Alvion Bio is built in the Lund life-science cluster in Skåne, southern Sweden. It is science born in the clinic, brought to the partners who turn it into care.
Supply cells at quality and scale, to those who turn them into cures.
Power cures that improve lives for patients and researchers worldwide.
Scientific rigour. Ethical sourcing. Uncompromising quality.
Who we serve
Four audiences, one promise: a dependable supply that lets them move forward ›
Across all four, the job is the same: remove the cell-supply risk so they can focus on the cure.
Therapy developers
Biotechs building cell and immune therapies who need a reliable, GMP-grade cell supply they can stake a programme on.
Clinicians & researchers
Physicians and scientists who care about consistency, safety and provenance, and need well-characterised, reproducible cells.
Partners
Collaborators building on a platform that scales with quality and ethics intact, focused on getting cures to patients.
What sets us apart
An ethical, proprietary amniotic source ›
Our cells come from term neonatal tissue (amniotic fluid) through a proprietary platform, . The source is ethically obtained, the cells are young and low in immunogenicity, and the process is ours. Competitors cannot simply replicate it.
We make and supply the cells so patients can benefit from new therapies ›